Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMKR vs GSK✓SelectedUSD · GSKAMKR vs GSK performance historyLatest closeAs of-2.72%11/13
Stock and ETF performance explorer

AMKR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+59.4%
GSK return
+65.8%
Excess return
-6.4%
Maximum drawdown
-67.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%+0.5%-3.2%-2.7%
7D+10.0%+1.1%+8.9%+10.1%
30D-19.4%+6.3%-25.8%-19.1%
3M-37.4%+1.8%-39.2%-37.1%
6M-51.5%+1.7%-53.1%-51.6%
YTD-8.1%+6.5%-14.6%-8.8%
1Y+13.8%+9.5%+4.3%+12.5%
3Y+59.4%+65.3%-5.9%+59.3%
All+59.4%+65.8%-6.4%+59.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling